1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research & Forecasting

2.1. Research Methodology
2.1.1. Research Process
2.1.2. Research Framework
2.1.3. Research Reliability & Validity
2.1.4. Research Assumptions
2.2. Forecasting Methodology

3. Executive Summary

3.1. Market Outlook
3.2. Market Data Feed

4. Premium Insight

4.1. Market Connectivity
4.2. Market Dynamics
4.2.1. Drivers
4.2.1.1. Increasing prevalence of vision impairment
4.2.1.2. Rising population of geriatric population
4.2.1.3. Minimally invasive alternative for presbyopia correction
4.2.2. Restraints
4.2.2.1. Lack of early diagnosis
4.2.3. Opportunities
4.2.3.1. Increasing market amalgamation activity
4.2.3.2. Technologically advanced treatment
4.2.4. Challenges
4.2.4.1. High cost associated with the treatment
4.3. Porters Five Forces Analysis
4.3.1. Threat of New Entrants
4.3.2. Threat of Substitutes
4.3.3. Bargaining Power of Customers
4.3.4. Bargaining Power of Suppliers
4.3.5. Industry Rivalry
4.4. Client Customizations

5. Global Myopia & Presbyopia Treatment Market, by Treatment

5.1. Overview
5.2. Market Sizing & Forecasting
5.3. Contact Lenses
5.4. Medication
5.5. Prescription Lenses
5.6. Surgery

6. Global Myopia & Presbyopia Treatment Market, by Indication

6.1. Overview
6.2. Market Sizing & Forecasting
6.3. Myopia
6.4. Presbyopia

7. Global Myopia & Presbyopia Treatment Market, by Geography

7.1. Overview
7.2. Market Sizing & Forecasting
7.3. Americas
7.3.1. Argentina
7.3.2. Brazil
7.3.3. Canada
7.3.4. Chile
7.3.5. Mexico
7.3.6. United States
7.4. Asia-Pacific
7.4.1. Australia
7.4.2. China
7.4.3. India
7.4.4. Indonesia
7.4.5. Japan
7.4.6. Malaysia
7.4.7. Philippines
7.4.8. South Korea
7.4.9. Thailand
7.5. Europe, Middle East & Africa
7.5.1. Denmark
7.5.2. France
7.5.3. Germany
7.5.4. Italy
7.5.5. Netherlands
7.5.6. Qatar
7.5.7. Russia
7.5.8. Saudi Arabia
7.5.9. South Africa
7.5.10. Spain
7.5.11. United Arab Emirates
7.5.12. United Kingdom

8. Competitive Landscape

8.1. FPNV Positioning Matrix
8.1.1. Quadrants
8.1.1.1. Forefront
8.1.1.2. Pathfinders
8.1.1.3. Niche
8.1.1.4. Vital
8.1.2. Business Strategy
8.1.2.1. Business Growth
8.1.2.2. Industry Coverage
8.1.2.3. Financial Viability
8.1.2.4. Channel Support
8.1.3. Product Satisfaction
8.1.3.1. Value for Money
8.1.3.2. Ease of Use
8.1.3.3. Product Features
8.1.3.4. Customer Support
8.2. Market Vendor Ranking Analysis
8.3. Competitive News Feed Analysis

9. Company Usability Profiles

9.1. Alcon Vision LLC
9.1.1. Overview
9.1.2. Strategy
9.1.3. SWOT
9.2. Bausch & Lomb Incorporated
9.2.1. Overview
9.2.2. Strategy
9.2.3. SWOT
9.3. Johnson & Johnson Vision
9.3.1. Overview
9.3.2. Strategy
9.3.3. SWOT
9.4. ZEISS International
9.4.1. Overview
9.4.2. Strategy
9.4.3. SWOT
9.5. Zeimer Ophthalmic Systems AG
9.5.1. Overview
9.5.2. Strategy
9.5.3. SWOT
9.6. ABB Optical Group
9.7. AccuLens
9.8. Blanchard Lab
9.9. CooperVision
9.10. Essilor Group
9.11. Euclid Systems Corporation
9.12. HAAG-STREIT GROUP
9.13. Menicon Co., Ltd.
9.14. NIDEK CO. LTD.
9.15. Topcon Corporation
10. Appendix
10.1. Discussion Guide
10.2. Author Details

Companies Mentioned

1. Alcon Vision LLC
2. Bausch & Lomb Incorporated
3. Johnson & Johnson Vision
4. Zeimer Ophthalmic Systems AG
5. ZEISS International
6. ABB Optical Group
7. AccuLens
8. Blanchard Lab
9. CooperVision
10. Essilor Group
11. Euclid Systems Corporation
12. HAAG-STREIT GROUP
13. Menicon Co., Ltd.
14. NIDEK CO. LTD.
15. Topcon Corporation